Personal information

No personal information available

Activities

Employment (2)

William Harvey Research Institute, Barts and The London School of Medicine and Dentistry: London, London, GB

2018-03-01 to present | Senior Research Fellow (Experimental Medicine and Musculoskeletal Sciences)
Employment
Source: Self-asserted source
Magdalena K Kaneva

UCB Pharma and William Harvey Research Institute, Barts and The London School of Medicine and Dentistry: London, GB

2011-09-01 to 2018-02-28 | Postdoctoral Fellow (Biochemical Pharmacology)
Employment
Source: Self-asserted source
Magdalena K Kaneva

Education and qualifications (2)

University of Westminster: London, GB

2007-10-01 to 2011-06-01 | PhD Immuno-pharmacology (Biomedical Sciences)
Qualification
Source: Self-asserted source
Magdalena K Kaneva

Jacobs University Bremen gGmbH: Bremen, DE

2004-09-01 to 2007-06-01 | BSc Biochemistry and Cell Biology (School of Engineering and Sciences)
Qualification
Source: Self-asserted source
Magdalena K Kaneva

Professional activities (5)

Centre for Predictive in vitro Models: London, GB

(QMUL)
Membership
Source: Self-asserted source
Magdalena K Kaneva

Centre for OA Pathogenesis Versus Arthritis: Oxford, GB

Member
Membership
Source: Self-asserted source
Magdalena K Kaneva

Higher Education Academy : London, GB

2011 to present | Associate Fellow
Membership
Source: Self-asserted source
Magdalena K Kaneva

British Pharmacological Society: London, GB

2010 to present | Fellow
Service
Source: Self-asserted source
Magdalena K Kaneva

University of East London: London, GB

2018-09-01 to 2019-05-31 | Visiting Lecturer in Systems Pharmacology (Pharmacology)
Invited position
Source: Self-asserted source
Magdalena K Kaneva

Works (12)

Neutrophil elastase and its inhibitors—overlooked players in osteoarthritis

The FEBS Journal
2022-01 | Journal article
Contributors: Magdalena K. Kaneva
Source: check_circle
Crossref

Alpha‐1‐antitrypsin reduces inflammation and exerts chondroprotection in arthritis

The FASEB Journal
2021-05 | Journal article
Contributors: Magdalena K. Kaneva; Milind M. Muley; Eugene Krustev; Allison R. Reid; Patricia R. Souza; Francesco Dell’Accio; Jason J. McDougall; Mauro Perretti
Source: check_circle
Crossref

Agrin induces long-term osteochondral regeneration by supporting repair morphogenesis

Science Translational Medicine
2020-09-02 | Journal article
Contributors: Suzanne E. Eldridge; Aida Barawi; Hui Wang; Anke J. Roelofs; Magdalena Kaneva; Zeyu Guan; Helen Lydon; Bethan L. Thomas; Anne-Sophie Thorup; Beatriz F. Fernandez et al.
Source: check_circle
Crossref

Identification of novel chondroprotective mediators in resolving inflammatory exudates

Journal of Immunology
2017 | Journal article
EID:

2-s2.0-85016231850

Contributors: Kaneva, M.K.; Greco, K.V.; Headland, S.E.; Montero-Melendez, T.; Mori, P.; Greenslade, K.; Pitzalis, C.; Moore, A.; Perretti, M.
Source: Self-asserted source
Magdalena K Kaneva via Scopus - Elsevier

Activation of Melanocortin Receptors MC<inf>1</inf> and MC<inf>5</inf> Attenuates Retinal Damage in Experimental Diabetic Retinopathy

Mediators of Inflammation
2016 | Journal article
EID:

2-s2.0-84962717077

Contributors: Rossi, S.; Maisto, R.; Gesualdo, C.; Trotta, M.C.; Ferraraccio, F.; Kaneva, M.K.; Getting, S.J.; Surace, E.; Testa, F.; Simonelli, F. et al.
Source: Self-asserted source
Magdalena K Kaneva via Scopus - Elsevier

Analyses on the mechanisms that underlie the chondroprotective properties of calcitonin

Biochemical Pharmacology
2014 | Journal article
EID:

2-s2.0-84925707221

Contributors: Greco, K.V.; Nalesso, G.; Kaneva, M.K.; Sherwood, J.; Iqbal, A.J.; Moradi-Bidhendi, N.; Dell'Accio, F.; Perretti, M.
Source: Self-asserted source
Magdalena K Kaneva via Scopus - Elsevier

Melanocortin peptides protect chondrocytes from mechanically induced cartilage injury

Biochemical Pharmacology
2014 | Journal article
EID:

2-s2.0-84908326448

Contributors: Kaneva, M.K.; Kerrigan, M.J.P.; Grieco, P.; Curley, G.P.; Locke, I.C.; Getting, S.J.
Source: Self-asserted source
Magdalena K Kaneva via Scopus - Elsevier

Resolution of inflammation: Examples of peptidergic players and pathways

Drug Discovery Today
2014 | Journal article
EID:

2-s2.0-84906310432

Contributors: Ahmed, T.J.; Kaneva, M.K.; Pitzalis, C.; Cooper, D.; Perretti, M.
Source: Self-asserted source
Magdalena K Kaneva via Scopus - Elsevier

Chondroprotective and anti-inflammatory role of melanocortin peptides in TNF-α activated human C-20/A4 chondrocytes

British Journal of Pharmacology
2012 | Journal article
EID:

2-s2.0-84864652059

Contributors: Kaneva, M.K.; Kerrigan, M.J.P.; Grieco, P.; Curley, G.P.; Locke, I.C.; Getting, S.J.
Source: Self-asserted source
Magdalena K Kaneva via Scopus - Elsevier

The phenotypic characterization of A13/BACii, a novel bovine chondrocytic cell line with differentiation potential

Cells Tissues Organs
2012 | Journal article
EID:

2-s2.0-84866038391

Contributors: Qusous, A.; Kaneva, M.; Can, V.C.; Getting, S.J.; Kerrigan, M.J.P.
Source: Self-asserted source
Magdalena K Kaneva via Scopus - Elsevier

Melanocortin peptide therapy for the treatment of arthritic pathologies

TheScientificWorldJournal
2009 | Journal article
EID:

2-s2.0-77449099049

Contributors: Getting, S.J.; Kaneva, M.; Bhadresa, Y.; Renshaw, D.; Leoni, G.; Patel, H.B.; Kerrigan, M.J.P.; Locke, I.C.
Source: Self-asserted source
Magdalena K Kaneva via Scopus - Elsevier

A role for MC3R in modulating lung inflammation

Pulmonary Pharmacology and Therapeutics
2008 | Journal article
EID:

2-s2.0-56949091561

Contributors: Getting, S.J.; Riffo-Vasquez, Y.; Pitchford, S.; Kaneva, M.; Grieco, P.; Page, C.P.; Perretti, M.; Spina, D.
Source: Self-asserted source
Magdalena K Kaneva via Scopus - Elsevier